A-174G/C polymorphism of the interleukin-6 gene in patients with lacunar infarction

被引:83
作者
Revilla, M
Obach, V
Cervera, A
Dávalos, A
Castillo, J
Chamorro, A
机构
[1] Univ Barcelona, Serv Neurol, Hosp Clin, E-08036 Barcelona, Spain
[2] Hosp Univ Doctor Josep Trueta, Neurol Sect, Girona, Spain
[3] Univ Santiago de Compostela, Hosp Clin, Serv Neurol, Santiago De Compostela, Spain
关键词
genetics; stroke; lacunar; interleukin-6; polymorphism;
D O I
10.1016/S0304-3940(02)00169-6
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Interleukin-6 (IL-6) is a pleiotropic cytokine that plays a central role in the pathogenesis of stroke. A base pair substitution -174G/C in the promoter region of the IL-6 gene regulates IL-6 gene expression. We compared the prevalence of this polymorphism in patients with lacunar stroke and in an age- and sex-matched cohort of asymptomatic controls. Eighty-two patients with lacunar stroke and 82 asymptomatic controls were prospectively assessed and genotyped for the 174G/C polymorphism in the promoter region of the IL-6 gene. Demographics and vascular risk factors were recorded in both groups. A brain computed tomography scan/magnetic resonance imaging confirmed the clinical diagnosis of lacunar stroke in all patients. The prevalence of CC genotype (18.3 vs. 7.3%, P = 0.03), and the frequency of C allele (42.7 vs. 31.1%, P = 0.03) were statistically significantly higher in patients with lacunar stroke than in asymptomatic controls. Expectedly, patients with lacunar stroke had a higher prevalence of vascular risk factors than asymptomatic controls. A logistic regression model showed that independent variables associated with lacunar stroke included history of hypertension (odds ratio (OR), 7.02; 95% confidence interval (95% CI), 3.11-15.81), diabetes (OR, 5.37; 95% CI, 1.52-18.89), hyperlipidemia (OR, 3.43; 95% CI, 1.04-11.25), smoking (OR, 5.84; 95% CI, 2.15-15.84), and CC genotype of the 174G/C IL-6 gene polymorphism (OR, 4.28; 95% CI, 1.22-15.00). These findings suggest that lacunar stroke might result from genetic susceptibility to inflammation-mediated damage in concert with atherosclerotic risk factors. (C) 2002 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:29 / 32
页数:4
相关论文
共 26 条
[1]   INTERLEUKIN-6 IN BIOLOGY AND MEDICINE [J].
AKIRA, S ;
TAGA, T ;
KISHIMOTO, T .
ADVANCES IN IMMUNOLOGY, VOL 54, 1993, 54 :1-78
[2]   Ischemia-induced interleukin-6 as a potential endogenous neuroprotective cytokine against NMDA receptor-mediated excitoxicity in the brain [J].
Ali, C ;
Nicole, O ;
Docagne, F ;
Lesne, S ;
MacKenzie, ET ;
Nouvelot, A ;
Buisson, A ;
Vivien, D .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2000, 20 (06) :956-966
[3]   INTERLEUKIN-6 AND INTERLEUKIN-1 RECEPTOR ANTAGONIST IN ACUTE STROKE [J].
BEAMER, NB ;
COULL, BM ;
CLARK, WM ;
HAZEL, JS ;
SILBERGER, JR .
ANNALS OF NEUROLOGY, 1995, 37 (06) :800-805
[4]   Cytokine actions in the central nervous system [J].
Benveniste, EN .
CYTOKINE & GROWTH FACTOR REVIEWS, 1998, 9 (3-4) :259-275
[5]  
BOLTEN J, 1995, LACUNAR OTHER SUBCOR, P56
[6]  
Bonafè M, 2001, EUR J IMMUNOL, V31, P2357, DOI 10.1002/1521-4141(200108)31:8<2357::AID-IMMU2357>3.0.CO
[7]  
2-X
[8]  
BOWCOCK A M, 1988, Genomics, V3, P8, DOI 10.1016/0888-7543(88)90152-8
[9]  
CASTELLANOS M, 2002, IN PRESS STROKE
[10]   Periventricular white matter lucencies in patients with lacunar stroke - A marker of too high or too low blood pressure? [J].
Chamorro, A ;
Pujol, J ;
Saiz, A ;
Vila, N ;
Vilanova, JC ;
Alday, M ;
Blanc, R .
ARCHIVES OF NEUROLOGY, 1997, 54 (10) :1284-1288